MarketGrader Europe 100 Index


Five Largest Companies
Symbol Name Grade Market Cap Country
ASML.NL ASML Holding NV 65.0 ¤405,266 NL
AZN.GB AstraZeneca PLC 68.7 ¤281,037 GB
SAP.DE SAP SE 58.9 ¤279,317 DE
HSBA.GB HSBC Holdings Plc 52.3 ¤264,379 GB
NOVN.CH Novartis AG 59.5 ¤257,002 CH

Five Smallest Companies
Symbol Name Grade Market Cap Country
SN.GB Smith & Nephew plc 60.5 ¤13,976 GB
ENX.FR Euronext NV 55.2 ¤14,825 NL
BIM.FR bioMerieux SA 50.2 ¤15,004 FR
SOON.CH Sonova Holding AG 49.1 ¤15,474 CH
PNR Pentair plc 55.2 ¤16,921 GB

Companies with Most Selections Among Current Components
Symbol Name Grade Times* Country
ASML.NL ASML Holding NV 65.0 33 NL
ACN Accenture Plc Class A 59.3 32 IE
DNB.NO DNB Bank ASA 59.8 29 NO
ALV.DE Allianz SE 50.5 28 DE
LR.FR Legrand SA 55.7 28 FR
NOVO.B.DK Novo Nordisk A/S Class B 60.7 28 DK
ASSA.B.SE ASSA ABLOY AB Class B 54.0 27 SE
TEL TE Connectivity plc 56.1 26 IE
ETN Eaton Corp. Plc 58.6 25 IE
SAND.SE Sandvik AB 53.6 24 SE
*Number of times selected at Index semi-annual reconstitutions since inception date.
Index Bio
Average Market Cap ¤72,659
Median Market Cap ¤43,259
Avg. 3 Mo. Dollar Vol. ¤170,750,259
Avg. 3 Mo. Trading Vol. 5,801,041
Last Rebalance Date 09/22/2025
Companies Replaced 49
Biggest Sector Increase Health Care
Biggest Sector Decrease Utilities

Fundamental Attributes
Trailing P/E Ratio (12 Mo.) 17.5
Forward P/E Ratio (12 Mo.) 15.2
Price/Book Ratio 3.3
Avg. Revenue Chg. - 3 Yr 26.0%
Avg. Op. Income Chg. - 3 Yr. 50.3%
Avg. EPS Growth - 3 Yr. 16.3%
Avg. EPS Growth - 1 Yr. 18.7%
Avg. Operating Margin 19.6%
Avg. LT Debt to Total Capital 40.2%
Avg. Return on Equity 16.8%
Dividend Yield 1.9%
Index Average Grade
Europe 100 Index 57.74
Country Breakdown
United Kingdom 22.0%
Germany 14.0%
Switzerland 10.0%
Ireland 10.0%
Netherlands 9.0%
Sweden 7.0%
France 7.0%
Italy 6.0%
Spain 5.0%
Denmark 2.0%
Belgium 2.0%
Norway 2.0%
Luxembourg 1.0%
Hong Kong 1.0%
Austria 1.0%
Finland 1.0%
For more information on this index please contact us

Get Access to the World's Smartest Global Research Platform

Don't wait another day to make better informed, higher-returning investments.

TRY IT FOR FREE